Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-05-27, Stock:JNJ, The news for the past five days is as follows:
2020-05-19: NEWS1: Johnson & Johnson to Stop Selling Talc-Based Baby Powder in U.S., Canada.NEWS2: Johnson & Johnson Stop Selling Talc-Based Baby Powder in U.S., Canada.NEWS3: Johnson & Johnson Pulls Baby Powder From U.S., Canada As Demand Plummets.NEWS4: J&J pulls sale of talc-based baby powder in North America.NEWS5: Johnson & Johnson to stop selling talc-based baby powder in U.S. and Canada.NEWS6: Johnson & Johnson to stop selling talc baby powder in U.S. and Canada.NEWS7: Top Stock Reports for Facebook, JNJ, FIS & Others.NEWS8: Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example'.NEWS9: Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results.NEWS10: Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results.NEWS11: Pandemic Seems to Last Forever. So Did Earnings Calls..NEWS12: A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals.NEWS13: Moderna’s Stock Has Tripled on Vaccine News. How to Tell if It’s Worth the Money..NEWS14: Market pros have high hopes for a COVID-19 vaccine: Morning Brief.NEWS15: Johnson & Johnson stops selling talc-based baby powder.
2020-05-20: NEWS1: Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain.NEWS2: Dow Jones Today: Pent Up Demand and Reopening in Sight.NEWS3: Dow ends 369 points higher as investors focus on American economy reopening.NEWS4: FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck.NEWS5: Johnson & Johnson Plans to Stop Selling Talc-Based Baby Powder.NEWS6: Dow Finishes Higher on Optimism Over U.S. Reopening.NEWS7: Dow Rises on Optimism Over U.S. Reopening.NEWS8: Dow up nearly 300 points, but off session highs after Senate passes bill to delist Chinese companies from U.S. exchanges.NEWS9: Dow Trades Higher as Wall Street Eyes U.S. Reopening.NEWS10: Johnson & Johnson Stops Selling Talc Baby Powder in U.S. - Here's the Trade.NEWS11: Another Biotech Stock Gets a Lift From Encouraging, but Early, Vaccine Data.NEWS12: Sorrento Therapeutics CEO: We are not a 'pump and dump' scheme.NEWS13: Dow Gains 400 Points as Wall Street Eyes U.S. Reopening.NEWS14: J&J to sell baby powder in UK despite stopping US sales.NEWS15: The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, Fidelity National Information Services, Alibaba and Bristol-Myers Squibb.NEWS16: J&J to Stop Sale of Talc-Based Baby Powder in North America.NEWS17: Johnson & Johnson, Target, Lowe's, Tesla - 5 Things You Must Know Wednesday.NEWS18: Johnson & Johnson To Discontinue Talc-Based Baby Powder in US and Canada.NEWS19: Johnson & Johnson Pulls Talc-Based Baby Powder From US, Canada As Cancer Claims Kill Demand.NEWS20: Johnson & Johnson to stop selling talc baby powder in U.S. and Canada.
2020-05-21: NEWS1: Fmr. CDC Official: 'we’re not cutting any corners' on COVID-19 vaccine development.NEWS2: For Moderna, a Coronavirus Vaccine Would Be the “Tip of the Iceberg”.
2020-05-22: NEWS1: Coronavirus latest: Friday, May 22.NEWS2: Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts.NEWS3: The race for a coronavirus treatment is fanning fears of 'vaccine nationalism'.NEWS4: Telehealth is going to 'become the default' for patients: Ro CEO.NEWS5: Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus.NEWS6: U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine — America would get 300 million doses beginning in October.NEWS7: The race for a coronavirus treatment is fanning fears of 'vaccine nationalism'.NEWS8: Pharma Stock Roundup: FDA Ok's Cancer Drugs for New Use, JNJ Stops US Baby Powder Sales.
2020-05-26: NEWS1: Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago.NEWS2: Novavax expects COVID-19 vaccine trial results in July.NEWS3: Hedge Funds Started Cashing Out Of Johnson & Johnson (JNJ) During The Crash.NEWS4: Is Abbott Stock A Buy As Coronavirus Test Accuracy Called Into Question?.NEWS5: The Zacks Analyst Blog Highlights: Bristol-Myers, Roche, AstraZeneca, Merck and Johnson & Johnson.NEWS6: Is Johnson & Johnson Stock A Buy As Pressure Mounts For A Coronavirus Vaccine?.NEWS7: 3 Dividend Stocks Ideal for Retirees.NEWS8: The More Covid-19 Vaccines, the Merrier.NEWS9: Merck leaps into COVID-19 development fray with vaccine, drug deals.

Answer: Rise